loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2001_133___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Pierre Fabre

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Pierre Fabre Medicament Gaillac FR (1)

    filter

    01 Ossein Hydroxyapatite Compound (1)

    filter

    01 France (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Pierre Fabre Medicament Gaillac FR

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ossein Hydroxyapatite Compound

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2001-133 - Rev 01
    Valid
    TSE
    2014-01-10
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-133 - Rev 01 of Pierre Fabre Medicament Gaillac Fr

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-133 - Rev 01 of Pierre Fabre Medicament Gaillac Fr 1

    20

    Pierre Fabre Medicament Gaillac Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for The 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group.

    One of their significant offerings is Ossein Hydroxyapatite Compound, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-133 - Rev 01

    This TSE Type CEP, issued on January 10, 2014, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Post Enquiry
    POST ENQUIRY